Uremic cardiomyopathy is responsible for high morbidity and mortality rates among patients
with chronic kidney disease (CKD), but the underlying mechanisms contributing to this …

Chronic kidney disease (CKD) triggers the risk of developing uremic cardiomyopathy as
characterized by cardiac hypertrophy, fibrosis and functional impairment. Traditionally …

BACKGROUND: Abnormal left ventricular (LV) deformation is an independent predictor of
poor cardiovascular outcome in end-stage renal disease. Studies in early-stage chronic …

To explain ventricular concentric and/or eccentric hypertrophy in chronic kidney disease,
past studies suggested that this was the result of increased preload and/or afterload. Using a …

Patients with advanced chronic kidney disease (CKD) mostly die from sudden cardiac death
and recurrent heart failure. The mechanisms of cardiac remodeling are largely unclear. To …

Chronic renal failure (CRF) is associated with an increased incidence of cardiovascular
diseases. Intensive research revealed a number of alterations in the heart during CRF; …

Impaired renal function with loss of nephron number in chronic renal disease (CKD) is
associated with increased cardiovascular morbidity and mortality. However, the structural …

Chronic kidney disease (CKD) affects millions of people globally and, for most patients, the
risk of developing cardiovascular disease is higher than that of progression to kidney failure …

Objectives A proof of concept cross-sectional study investigating changes in myocardial
abnormalities across stages of chronic kidney disease (CKD). Characterizing noninvasive …

Cardiovascular disease constitutes the leading cause of mortality in patients with chronic
kidney disease (CKD) and end-stage renal disease. Despite increasing recognition of a …